Search for: "AstraZeneca UK Ltd." Results 1 - 20 of 82
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
19 Oct 2021, 1:52 pm by Hyun Woo Kang
Short shrift was given to the Marhedge decision and Eyre J agreed with the judge in the subsequent decision of AstraZeneca UK Ltd v. [read post]
8 Feb 2021, 9:16 am by Matthieu Dhenne (Ipsilon)
Readers of the Blog should remember the French landmark French judgment rendered in September 2020 in the European Pemetrexed saga, which condemned Fresenius to pay € 28 million in damages (see here). [read post]
5 Jul 2017, 11:34 am
 Canadian Supreme Court holds promise doctrine "unsound" in AstraZeneca v Apotex Nexium disputeThe AmeriKat Annsley provides a timely and in-depth analysis on the much-awaited decision rendered by the Supreme Court of Canada in the appeal between AstraZeneca Canada v Apotex (2017 SCC 36). [read post]
22 Jun 2015, 9:24 am
B+ subgroup asks for commentsThe UK Intellectual Property Office's CEO, John Alty CB is chairman of a group of representatives from countries and organisations known as Group B+ which focuses on patent harmonisation. [read post]
15 Jun 2015, 7:13 am
Wathelet gives Nestlé application a bit of stickCJEU’s Advocate General Wathelet delivered his Opinion in the keenly-awaited dispute in Case C‑215/14Société des Produits Nestlé SA v Cadbury UK Ltd, a reference from Mr Justice Arnold in the Chancery Division of the High Court, England and Wales [noted by the IPKat here and here]. [read post]
8 Jun 2015, 4:20 am
******************PREVIOUSLY, ON NEVER TOO LATE Never too late 48 [week ending on Sunday 31 May] - The meaning of EPO appeal system | 3D Printing and the law | Epo and external investigation firms | Umbrella designs | US Supreme Court in Commil USA, LLC v Cisco Systems | European Inventor Award | FIFA and brand integrity | Warner-Lambert v Actavis |  Wine in Black GmbH v OHIM | IP and busking | Swiss-style claims.Never too late… [read post]
1 Jun 2015, 3:33 pm
******************PREVIOUSLY, ON NEVER TOO LATE Never too late 47 [week ending on Sunday 24 May]  - Nicolas Sarkozy and the IP | Another reference on TM licences to the CJEU | UPC test-drive | Swatch v Swatchball | New Lisbon Treaty on appellations of origin and geographical indications | UP reneal fees | Synthon v Teva | GC on Yoshida | UPC Court fees event | EPO staff under fire | The trade-secret option | Damages |AstraZeneca AB & Another v KRKA dd… [read post]
25 May 2015, 4:15 am
Ltd [on which see the IPKat's earlier post here], a trade mark dispute concerning a Community trade mark resembling a knife-handle.* Do you value an invitation to the UPC court fees consultation event? [read post]
22 May 2015, 10:38 am
Krka agreed to submit to AstraZeneca's application, on the basis that AstraZeneca gave the usual cross-undertaking in damages, which it duly did.However, at around the same time, another generic company, Ranbaxy (UK) Ltd, began proceedings in respect of the same patent, challenging its validity. [read post]
14 May 2015, 4:00 am by Paula Bremner
In the past five years, the Canadian Federal Court has invalidated several patents based on an arguably “technical” deficiency – the “Promise/utility” requirement. [read post]
17 Nov 2014, 9:59 pm by Patent Docs
Pharmadax USA, Inc. et al. 1:14-cv-07105; filed November 3, 2014 in the District Court of New Jersey • Plaintiffs: AstraZeneca Pharmaceuticals LP; AstraZeneca UK Ltd. [read post]
26 Oct 2014, 9:17 pm by Patent Docs
Pharmadax USA, Inc. et al. 8:14-cv-01710; filed October 23, 2014 in the Central District of California • Plaintiffs: AstraZeneca Pharmaceuticals LP; AstraZeneca UK Ltd. [read post]
8 Sep 2014, 4:55 am
.* The skilled person - more knowledgeable than ever beforeDavid covers the exciting pharma-patent ruling in Teva UK Limited & another v AstraZeneca AB [2014] EWHC 2873 (Pat) by Mr Justice Sales in the Patents Court for England and Wales, which focuses on the concept of Common General Knowledge (CGK). [read post]
27 Jul 2014, 5:07 pm by INFORRM
On 22 July 2014, HHJ Moloney QC heard an application in the harassment case of AstraZeneca UK Ltd & anr v Mathai & ors. [read post]